A new algorithm for the management of COPD

The Lancet Respiratory Medicine

Volumn 3, Issue 4, 2015, Pages 266-268

  Cooper, Christopher B ^a   Barjaktarevic, Igor ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACLIDINIUM BROMIDE PLUS FORMOTEROL FUMARATE; ANTICOAGULANT AGENT; AZITHROMYCIN; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; DIURETIC AGENT; GLYCOPYRRONIUM BROMIDE PLUS INDACATEROL; IPRATROPIUM BROMIDE PLUS SALBUTAMOL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; MORPHINE; MUCOLYTIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; OLODATEROL PLUS TIOTROPIUM BROMIDE; ROFLUMILAST; SHORT ACTING DRUG; UMECLIDINIUM PLUS VILANTEROL;

ALGORITHM; ASTHMA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BRONCHIOLITIS OBLITERANS; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DYSPNEA; EXERCISE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERCAPNIA; HYPOXEMIA; LUNG CLEARANCE; LUNG EMBOLISM; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG TRANSPLANTATION; NOTE; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SMOKING CESSATION; WHEEZING; LUNG RESECTION; OXYGEN THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY CARE; SEVERITY OF ILLNESS INDEX;

ADRENERGIC BETA-AGONISTS; ALGORITHMS; BRONCHODILATOR AGENTS; FORCED EXPIRATORY VOLUME; HUMANS; MUSCARINIC ANTAGONISTS; OXYGEN INHALATION THERAPY; PNEUMONECTOMY; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION;

EID: 84926305704     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00091-0     Document Type: Note

References (15)

1. Vestbo J, Hurd SS, Rodriguez-Roisin R The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)-why and what?. Clin Respir J 2012, 6:208-214.
2. Cooper CB, Tashkin DP Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease. BMJ 2005, 330:640-644.
3. Zuwallack R, De Salvo MC, Kaelin T Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. Respir Med 2010, 104:1179-1188.
4. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. Chest 1994, 105:1411-1419. COMBIVENT Inhalation Aerosol Study Group.
5. Bateman ED, Hurd SS, Barnes PJ Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008, 31:143-178.
6. Zhang M, Li Q, Zhang XY, Ding X, Zhu D, Zhou X Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease. Eur J Clin Microbiol Infect Dis 2010, 29:1487-1493.
7. Albert RK, Connett J, Bailey WC Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011, 365:689-698.
8. Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009, 374:685-694. for the M2-124 and M2-125 study groups.
9. Rizkallah J, Man SF, Sin DD Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest 2009, 135:786-793.
10. Naunheim KS, Wood DE, Mohsenifar Z, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006, 82:431-443.
11. Miller JD, Malthaner RA, Goldsmith CH, et al. A randomized clinical trial of lung volume reduction surgery versus best medical care for patients with advanced emphysema: A two-year study from Canada. Ann Thorac Surg 2006, 81:314-321. for the Canadian Lung Volume Reduction Surgery Study.
12. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013, 188:e13-e64.
13. Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007, 26:782-795.
14. A clinical trial. Ann Intern Med 1983, 99:612-620. Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease.
15. Boehler A, Estenne M Obliterative bronchiolitis after lung transplantation. Curr Opin Pul Med 2000, 6:133-139.